MPT: DAPT Improves CABG Vein Graft Patency

ACC Conference Reporter

AHA 2017 | ANAHEIM — Dual antiplatelet therapy with ticagrelor (Brilinta) and aspirin significantly improved saphenous vein graft (SVG) patency 1 year after coronary artery bypass graft (CABG) versus monotherapy, without an excess risk for major bleeding, researchers reported here. Read More >>>

Keywords: AHA Annual Scientific Sessions, AHA17

< Back to Listings